Literature DB >> 16622234

Characterization of MspA, an immunogenic autotransporter protein that mediates adhesion to epithelial and endothelial cells in Neisseria meningitidis.

D P J Turner1, A G Marietou, L Johnston, K K L Ho, A J Rogers, K G Wooldridge, D A A Ala'Aldeen.   

Abstract

A novel putative autotransporter protein (NMB1998) was identified in the available genomic sequence of meningococcal strain MC58 (ET-5; ST-32). The mspA gene is absent from the genomic sequences of meningococcal strain Z2491 (ET-IV; ST-4) and the gonococcal strain FA1090. An orthologue is present in the meningococcal strain FAM18 (ET-37; ST-11), but the sequence contains a premature stop codon, suggesting that the protein may not be expressed in this strain. MspA is predicted to be a 157-kDa protein with low cysteine content, and it exhibits 36 and 33% identity to the meningococcal autotransporter proteins immunoglobulin A1 (IgA1) protease and App, respectively. Search of the Pfam database predicts the presence of IgA1 protease and autotransporter beta-barrel domains. MspA was cloned, and a recombinant protein of the expected size was expressed and after being affinity purified was used to raise rabbit polyclonal monospecific antiserum. Immunoblot studies showed that ca. 125- and 95-kDa fragments of MspA are secreted in meningococcal strain MC58, which are absent from the isogenic mutant. Secretion of MspA was shown to be modified in an AspA isogenic mutant. A strain survey showed that MspA is expressed by all ST-32 and ST-41/44 (lineage 3) strains, but none of the ST-8 (A4) strains examined. Sera from patients convalescing from meningococcal disease were shown to contain MspA-specific antibodies. In bactericidal assays, anti-MspA serum was shown to kill the homologous strain (MC58) and another ST-32 strain. Escherichia coli-expressing recombinant MspA was shown to adhere to both human bronchial epithelial cells and brain microvascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622234      PMCID: PMC1459726          DOI: 10.1128/IAI.74.5.2957-2964.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine.

Authors:  E de Kleijn; L van Eijndhoven; C Vermont; B Kuipers; H van Dijken; H Rümke; R de Groot; L van Alphen; G van den Dobbelsteen
Journal:  Vaccine       Date:  2001-11-12       Impact factor: 3.641

2.  Subtilisin-like autotransporter serves as maturation protease in a bacterial secretion pathway.

Authors:  L Coutte; R Antoine; H Drobecq; C Locht; F Jacob-Dubuisson
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

3.  In vivo expression of Neisseria meningitidis proteins homologous to the Haemophilus influenzae Hap and Hia autotransporters.

Authors:  P van Ulsen; L van Alphen; C T Hopman; A van der Ende; J Tommassen
Journal:  FEMS Immunol Med Microbiol       Date:  2001-12

4.  Differences in surface expression of NspA among Neisseria meningitidis group B strains.

Authors:  G R Moe; S Tan; D M Granoff
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 5.  Vaccine prevention of meningococcal disease, coming soon?

Authors:  S L Morley; A J Pollard
Journal:  Vaccine       Date:  2001-12-12       Impact factor: 3.641

Review 6.  Development of vaccines against meningococcal disease.

Authors:  Luis Jódar; Ian M Feavers; David Salisbury; Dan M Granoff
Journal:  Lancet       Date:  2002-04-27       Impact factor: 79.321

7.  A conserved region within the Bordetella pertussis autotransporter BrkA is necessary for folding of its passenger domain.

Authors:  David C Oliver; George Huang; Elena Nodel; Steve Pleasance; Rachel C Fernandez
Journal:  Mol Microbiol       Date:  2003-03       Impact factor: 3.501

8.  Autotransported serine protease A of Neisseria meningitidis: an immunogenic, surface-exposed outer membrane, and secreted protein.

Authors:  David P J Turner; Karl G Wooldridge; Dlawer A A Ala'Aldeen
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

9.  GNA33 from Neisseria meningitidis serogroup B encodes a membrane-bound lytic transglycosylase (MltA).

Authors:  Gary T Jennings; Silvana Savino; Elisa Marchetti; Beatrice Aricò; Thomas Kast; Lucia Baldi; Astrid Ursinus; Joachim-Volker Höltje; Robert A Nicholas; Rino Rappuoli; Guido Grandi
Journal:  Eur J Biochem       Date:  2002-08

10.  NadA, a novel vaccine candidate of Neisseria meningitidis.

Authors:  Maurizio Comanducci; Stefania Bambini; Brunella Brunelli; Jeannette Adu-Bobie; Beatrice Aricò; Barbara Capecchi; Marzia Monica Giuliani; Vega Masignani; Laura Santini; Silvana Savino; Dan M Granoff; Dominique A Caugant; Mariagrazia Pizza; Rino Rappuoli; Marirosa Mora
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

View more
  38 in total

Review 1.  From self sufficiency to dependence: mechanisms and factors important for autotransporter biogenesis.

Authors:  Denisse L Leyton; Amanda E Rossiter; Ian R Henderson
Journal:  Nat Rev Microbiol       Date:  2012-02-16       Impact factor: 60.633

2.  Entry of Neisseria meningitidis into mammalian cells requires the Src family protein tyrosine kinases.

Authors:  Heiko Slanina; Alexandra König; Sabrina Hebling; Christof R Hauck; Matthias Frosch; Alexandra Schubert-Unkmeir
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

3.  Autoprocessing of the Escherichia coli AIDA-I autotransporter: a new mechanism involving acidic residues in the junction region.

Authors:  Marie-Eve Charbonneau; Julie Janvore; Michael Mourez
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

4.  Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage.

Authors:  Mohamed Alamro; Fadil A Bidmos; Hannah Chan; Neil J Oldfield; Emma Newton; Xilian Bai; Jack Aidley; Rory Care; Claire Mattick; David P J Turner; Keith R Neal; Dlawer A A Ala'aldeen; Ian Feavers; Ray Borrow; Christopher D Bayliss
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

Review 5.  A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C.

Authors:  Yordanka Masforrol; Jeovanis Gil; Darien García; Jesús Noda; Yassel Ramos; Lázaro Betancourt; Osmany Guirola; Sonia González; Boris Acevedo; Vladimir Besada; Osvaldo Reyes; Luis Javier González
Journal:  Hum Vaccin Immunother       Date:  2017-10-30       Impact factor: 3.452

6.  Modification of lipooligosaccharide with phosphoethanolamine by LptA in Neisseria meningitidis enhances meningococcal adhesion to human endothelial and epithelial cells.

Authors:  Hideyuki Takahashi; Russel W Carlson; Artur Muszynski; Biswa Choudhury; Kwang Sik Kim; David S Stephens; Haruo Watanabe
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

Review 7.  Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease.

Authors:  Darryl J Hill; Natalie J Griffiths; Elena Borodina; Mumtaz Virji
Journal:  Clin Sci (Lond)       Date:  2010-02-09       Impact factor: 6.124

Review 8.  Pathogenic neisseriae: surface modulation, pathogenesis and infection control.

Authors:  Mumtaz Virji
Journal:  Nat Rev Microbiol       Date:  2009-04       Impact factor: 60.633

9.  The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier.

Authors:  Nina M van Sorge; Darin Quach; Michael A Gurney; Paul M Sullam; Victor Nizet; Kelly S Doran
Journal:  J Infect Dis       Date:  2009-05-15       Impact factor: 5.226

10.  Transcriptional profiling of Neisseria meningitidis interacting with human epithelial cells in a long-term in vitro colonization model.

Authors:  Ariann Hey; Ming-Shi Li; Michael J Hudson; Paul R Langford; J Simon Kroll
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.